Titles and Roles
- Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Discovery and Developmental Therapeutics
Fadlo R. Khuri, MD, is the 16th president of the American University of Beirut in Lebanon. Dr. Khuri maintains his appointment as Professor of the Department of Hematology and Medical Oncology at Emory University School of Medicine. He is the former Executive Associate Dean of Research and the former Chair of the Department of Hematology and Medical Oncology at Emory University School of Medicine. He also served as Deputy Director for the Winship Cancer Institute of Emory University.
Dr. Khuri was also the Roberto C. Goizueta Distinguished Chair for Cancer Research. In his 13 years at Emory, he was instrumental in leading the development of some of the most important cancer-related programs in the state of Georgia and throughout the nation.
Dr. Khuri continues to serve as editor-in-chief of the journal Cancer.
Dr. Khuri earned his bachelor's degree from Yale University, in New Haven, CT, and his medical degree from Columbia University, College of Physicians and Surgeons, in New York, NY. He completed his residency in internal medicine at the Boston City Hospital, Boston University School of Medicine. He then completed a fellowship in hematology and medical oncology at the New England Medical Center, Tufts University School of Medicine. He is certified by the American Board of Internal Medicine in Internal Medicine and Medical Oncology and is an active member of the American Association for Cancer Research, and the American Society of Clinical Oncology. He was on faculty at the University of Texas M.D. Anderson Cancer Center from 1995-2002 prior to joining Winship.
His research interests include development of molecular, prognostic, therapeutic, and chemopreventive approaches to improve the standard of care for patients with tobacco related cancers. His laboratory is investigating the mechanism of action of signal transduction inhibitors in tobacco related cancers.
He serves on the editorial boards of seven journals, including the Journal of Clinical Oncology, Clinical Cancer Research and Cancer, and has published over 100 peer reviewed articles in elite journals including Nature Medicine, Journal of the National Cancer Institute, Cancer Research and the Journal of Clinical Oncology.
Dr. Khuri is the recipient of numerous awards, including being listed among America's Top Doctors and the Marquis Who's Who in the World. He is the recipient of a Georgia Cancer Coalition Distinguished Clinical Scholar Award. In 2013, he received the prestigious AACR Richard and Hinda Rosenthal Award for groundbreaking contributions in lung and aerodigestive medical oncology. In 2014, he was elected by his peers as an American Association for the Advancement of Science Fellow. In 2015, Dr. Khuri was selected as a member of the Académie des Sciences du Liban (ASL) for his creativity in addressing biological problems and generating innovative approaches in cancer therapy. Dr. Khuri also received the 2015 James R. Eckman Award for Teaching Excellence, Winship Cancer Institute Fellowship Program. He has been the recipient of competitive, peer-reviewed federal grant support from the National Cancer Institute, Department of Defense, and American Cancer Society over the last decade.